MeiraGTx Holdings plc Profile Avatar - Palmy Investing

MeiraGTx Holdings plc

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following…

Biotechnology
US, New York [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

MeiraGTx Holdings plc can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

MeiraGTx Holdings plc can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of MeiraGTx Holdings plc.

If you want to see a demo, head over to the financial segments of AAPL

End of MGTX's Analysis
CIK: 1735438 CUSIP: G59665102 ISIN: KYG596651029 LEI: - UEI: -
Secondary Listings
MGTX has no secondary listings inside our databases.